The Relationship Between Advanced Lung Cancer Inflammation Index and Adverse Clinical Outcomes in Patients with Myocardial Infarction with No-Obstructive Coronary Arteries

• Published in: Journal of inflammation research Vol. 18; no. Issue 1; pp. 9907 - 9917
• Main Authors: Zhao, Hong-wei, Wang, Cheng-fu
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 2025; Taylor & Francis Ltd; Dove; Dove Medical Press
• Subjects: advanced lung cancer inflammation index; Albumin; Angina; Angina pectoris; Antilipemic agents; Arteries; Blood; Blood cell count; Body mass index; Cardiac function; Cardiac patients; Cardiovascular diseases; Care and treatment; Cerebral infarction; China; Clinical outcomes; Congestive heart failure; Coronary artery; Coronary artery bypass; Coronary vessels; Heart attack; Heart attacks; Heart failure; Hospitals; Hypertension; Inflammation; Kinases; Laboratories; Leukocytes (neutrophilic); Lung cancer; Lymphocytes; major adverse cardiovascular and cerebrovascular events; Medical prognosis; Mortality; Myocardial infarction; myocardial infarction with no-obstructive coronary arteries; Natriuretic peptides; Neutrophils; Normal distribution; Original Research; Patient outcomes; Population; predictor; Prognosis; Regression analysis; Risk factors; Troponin I; China; major adverse cardiovascular and cerebrovascular events; myocardial infarction with no-obstructive coronary arteries; predictor; advanced lung cancer inflammation index

The advanced lung cancer inflammation index (ALI) has been suggested as a reliable prognostic indicator for cardiovascular disease. However, the association between ALI and the prognosis of patients with myocardial infarction with no-obstructive coronary arteries (MINOCA) remains undetermined. In th...